公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2008 | Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of Gram-positive cocci | Tsao S.-M.; Lin H.-C.; Lee C.-M.; Hsu G.-J.; Chen C.-M.; Sun W.; Liu Y.-C.; Jang T.-N.; Cheng Y.-J.; Lu P.-L.; Chiang P.-C.; Wang L.-S.; HSIANG-CHI KUNG ; Chuang Y.-C.; Shi Z.-Y.; Liu J.-W.; Huang C.-H.; Lu C.-T.; Liao C.-H.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 6 | 6 | |
2001 | Occupational exposure to wood, formaldehyde, and solvents and risk of nasopharyngeal carcinoma | Hildesheim A.; Dosemeci M.; CHANG-CHUAN CHAN ; Chen C.-J.; Cheng Y.-J.; Hsu M.-M.; Chen I.-H.; Mittl B.F.; Sun B.; Levine P.H.; Chen J.-Y.; Brinton L.A.; Yang C.-S. | Cancer Epidemiology Biomarkers and Prevention | 139 | 107 | |
2020 | Plasma-activated medium as adjuvant therapy for lung cancer with malignant pleural effusion | Cheng Y.-J.; CHING-KAI LIN ; Chen C.-Y.; Chien P.-C.; Chuan H.-H.; CHAO-CHI HO ; Cheng Y.-C. | Scientific Reports | 7 | 6 | |
2011 | Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families | Yu K.J.; Hsu W.-L.; Pfeiffer R.M.; CHUN-JU CHIANG ; CHENG-PING WANG ; PEI-JEN LOU ; Cheng Y.-J.; Gravitt P.; Diehl S.R.; Goldstein A.M.; Chen C.-J.; Hildesheim A. | Clinical Cancer Research | 53 | 49 | |
2014 | Reply | Hung M.-H.; Cheng Y.-J.; JIN-SHING CHEN | Annals of Thoracic Surgery | 0 | 0 | |
2016 | Site-controlled crystalline growth of InN on GaN substrate and its photoluminscence | Kuo C.-T; Hsu L.-H; Lai Y.-Y; Kuo H.-C; CHIEN-CHUNG LIN ; Cheng Y.-J. | 2016 Conference on Lasers and Electro-Optics, CLEO 2016 | 0 | 0 | |
2012 | Trends in susceptibility of vancomycin-resistant Enterococcus faecium to tigecycline, daptomycin, and linezolid and molecular epidemiology of the isolates: Results from the Tigecycline in Vitro Surveillance in Taiwan (TIST) study, 2006 to 2010 | Tsai H.-Y.; Liao C.-H.; Chen Y.-H.; Lu P.-L.; Huang C.-H.; Lu C.-T.; Chuang Y.-C.; Tsao S.-M.; Chen Y.-S.; Liu Y.-C.; Chen W.-Y.; Jang T.-N.; Lin H.-C.; Chen C.-M.; Shi Z.-Y.; SUNG-CHING PAN ; Yang J.-L.; HSIANG-CHI KUNG ; Liu C.-E.; Cheng Y.-J.; Liu J.-W.; Sun W.; Wang L.-S.; Ko W.-C.; Yu K.-W.; Chiang P.-C.; Lee M.-H.; Lee C.-M.; Hsu G.-J.; PO-REN HSUEH | Antimicrobial Agents and Chemotherapy | 21 | 19 | |
2013 | Trends in the antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae: Results from the Tigecycline in Vitro Surveillance in Taiwan (TIST) study, 2006-2010 | Tsai H.-Y.; Chen Y.-H.; Liao C.-H.; Lu P.-L.; Huang C.-H.; Lu C.-T.; Chuang Y.-C.; Tsao S.-M.; Chen Y.-S.; Liu Y.-C.; Chen W.-Y.; Jang T.-N.; Lin H.-C.; Chen C.-M.; Shi Z.-Y.; SUNG-CHING PAN ; Yang J.-L.; HSIANG-CHI KUNG ; Liu C.-E.; Cheng Y.-J.; Liu J.-W.; Sun W.; Wang L.-S.; Ko W.-C.; Yu K.-W.; Chiang P.-C.; Lee M.-H.; Lee C.-M.; Hsu G.-J.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 11 | 11 | |
2012 | Trends in the susceptibility of clinically important resistant bacteria to tigecycline: Results from the tigecycline In Vitro surveillance in Taiwan study, 2006 to 2010 | Chen Y.-H.; Lu P.-L.; Huang C.-H.; Liao C.-H.; Lu C.-T.; Chuang Y.-C.; Tsao S.-M.; Chen Y.-S.; Liu Y.-C.; Chen W.-Y.; Jang T.-N.; Lin H.-C.; Chen C.-M.; Shi Z.-Y.; SUNG-CHING PAN ; Yang J.-L.; HSIANG-CHI KUNG ; Liu C.-E.; Cheng Y.-J.; Liu J.-W.; Sun W.; Wang L.-S.; Ko W.-C.; Yu K.-W.; Chiang P.-C.; Lee M.-H.; Lee C.-M.; Hsu G.-J.; PO-REN HSUEH | Antimicrobial Agents and Chemotherapy | 39 | 35 | |
2014 | Trends in the susceptibility of methicillin-resistant Staphylococcus aureus to nine antimicrobial agents, including ceftobiprole, nemonoxacin, and tyrothricin: Results from the Tigecycline in Vitro Surveillance in Taiwan (TIST) study, 2006-2010 | Chen Y.-H.; Liu C.-Y.; Ko W.-C.; Liao C.-H.; Lu P.-L.; Huang C.-H.; Lu C.-T.; Chuang Y.-C.; Tsao S.-M.; Chen Y.-S.; Liu Y.-C.; Chen W.-Y.; Jang T.-N.; Lin H.-C.; Chen C.-M.; Shi Z.-Y.; SUNG-CHING PAN ; Yang J.-L.; HSIANG-CHI KUNG ; Liu C.-E.; Cheng Y.-J.; Liu J.-W.; Sun W.; Wang L.-S.; Yu K.-W.; Chiang P.-C.; Lee M.-H.; Lee C.-M.; Hsu G.-J.; PO-REN HSUEH | European Journal of Clinical Microbiology and Infectious Diseases | 22 | 19 | |
2011 | Unique variants of human papillomavirus genotypes 52 and 58 and risk of cervical neoplasia | Chang Y.-J.; Chen H.-C.; Lee B.-H.; You S.-L.; Lin C.-Y.; Pan M.-H.; Chou Y.-C.; CHANG-YAO HSIEH ; Chen Y.-M.A.; Cheng Y.-J.; Chen C.-J. | International Journal of Cancer | 41 | 38 | |